Skip to main content
OpenTrials
Completed

NCT Number: NCT01150435

Driving Ability of Drug Dependant Patients in Maintenance Therapy

"Mobility" is a contributing factor in today's society. Drug dependence displays not only a medical but also an economic problem: Especially for an intended reintegration of a drug dependant patient in maintenance therapy the possession of a driving licence could be decisive for a job allocation and therefore the intended reintegration to society.

Subject of this study was to verify if patients under substitution therapy with R, S- Methadone, S- Methadone, Buprenorphine and Buprenorphine plus Naloxone are just as fit to drive a car as a non drug dependent person.

For this investigation we compared 121 drug dependent patients in stable maintenance therapy for a minimum of two years without consumption of any other psychotropic substances than their maintenance drug (including THC) with non- drug dependant subjects of the same gender, age and level of education.

This is the largest study on this topic worldwide. The neuro- cognitive working order was tested by means of the "Vienna Test System" an objective, reliable and valid test quantifying reaction time, attention efficiency, concentration, maximum resilience and orientation. Current use of any other psychotropic substance or alcohol just as any serious illness (including psychiatric diseases, except for an effectively treated depression) lead to exclusion from this study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Institut für Rechtsmedizin

Munich, Baveria, 80336, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Drug dependent patients in stable maintenance therapy for a minimum of two years without consumption of any other psychotropic substances than their maintenance drug (including THC)
  • Written agreement on attending this study after full clarification
  • majority

Exclusion criteria

  • Patients, who do not approve or are not able to approve, to this study
  • Patients, who are not legally competent
  • Patients in emergency situations
  • Patients under age
  • Consumption of any other psychotropic substances than the maintenance drug
  • Severe illnesses p.e. malignant diseases, serious psychiatric illness

Sponsors and collaborators

Lead sponsor

Hummel, Christiane

Indiv

Collaborators

  • Ludwig-Maximilians - University of Munich

Registry information

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Jun 25, 2010
Registry last updated
Jun 25, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.